Delivery Order SPE2DR25D2014-SPE2DR26FZ90Z
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.76 for Freestyle Libre 3 Plus Sensors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $20,855.30 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus sensors on December 1, 2025, with completion targeted for December 2, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor serving military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $4,368.94 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 17, 2025, with completion expected by October 20, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The sensors will be supplied from the...
- The Defense Logistics Agency awarded a $10,128.00 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a $25,922.92 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order is being fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,884.50 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on December 8, 2025, with a completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,394.90 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside, firm fixed price contract represents a single delivery order fulfilling immediate federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus sensors on September 24, 2025, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order represents a small-value medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a $10,945.34 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $2,855.64 on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ90ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,941.80 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The Freestyle Libre 3 Plus Sensors delivery falls within the company's extensive portfolio of diabetes management and specialized medical supply deliveries under the DLA's pharmaceutical prime vendor framework, which enables the company to supply a comprehensive range of medications and medical devices to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/7/25 |